Monoline Rx Ii, L.p. - Net Worth and Insider Trading

Monoline Rx Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Monoline Rx Ii, L.p. owns 1 companies in total, including Aquestive Therapeutics Inc (AQST) .

Click here to see the complete history of Monoline Rx Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Monoline Rx Ii, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
AQST	Aquestive Therapeutics Inc	2018-07-24	10 percent owner

Monoline Rx Ii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Monoline Rx Ii, L.p. Ownership Network

Ownership Network List of Monoline Rx Ii, L.p.

No Data

Ownership Network Relation of Monoline Rx Ii, L.p.

Monoline Rx Ii, L.p. Owned Company Details

What does Aquestive Therapeutics Inc do?

Who are the key executives at Aquestive Therapeutics Inc?

Monoline Rx Ii, L.p. is the 10 percent owner of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include director & Chief Innovation/Tech Officer Alexander Mark Schobel , Chief Medical Officer Carl N Kraus , and SVP & Research & Development Stephen Wargacki .

Aquestive Therapeutics Inc (AQST) Insider Trades Summary

Over the past 18 months, Monoline Rx Ii, L.p. made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel ,

In summary, during the past 3 months, insiders sold 0 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.

Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aquestive Therapeutics Inc Insider Transactions

No Available Data

Monoline Rx Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Monoline Rx Ii, L.p.. You might contact Monoline Rx Ii, L.p. via mailing address: C/o Bratton Capital Management, 201 Main Street, Suite 1900, Fort Worth Tx 76102.

Discussions on Monoline Rx Ii, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.